İş dünyası · 03.11.20261 dk okuma
Zuellig Pharma Strengthens Clinical Sourcing Capabilities in China through Strategic Acquisition
Yerel otomatik çeviri · Kaynağın orijinal dili
Özet
The acquisition of our newly licensed Hangzhou facility establishes robust local sourcing capabilities to accelerate and support clinical trials across China HANGZHOU, China, Nov.